Anzeige
Mehr »
Samstag, 07.02.2026 - Börsentäglich über 12.000 News
Der Shakeout: Silber hat genau das getan, was echte Bullenmärkte immer tun - es hat die Touristen abgeschüttelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14XZH | ISIN: FR0012882389 | Ticker-Symbol: PHF
Tradegate
06.02.26 | 21:55
38,600 Euro
0,00 % 0,000
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
EQUASENS SA Chart 1 Jahr
5-Tage-Chart
EQUASENS SA 5-Tage-Chart
RealtimeGeldBriefZeit
38,50038,75013:05
38,50038,65006.02.

Aktuelle News zur EQUASENS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoEQUASENS: Strong commercial performance in 2025: Annual Recurring Revenue (ARR) of €108.0m (+8.8% as reported on 31 December 2025) and full-year revenue of €236.5m (+9.1% as reported)187Villers-lès-Nancy, 05 February 2026 - 6:00 PM (CET) PRESS RELEASE Strong commercial performance in 2025: Annual Recurring Revenue (ARR) of €108.0m (+8.8% as reported on 31 December 2025) and full-year...
► Artikel lesen
05.11.25Equasens: Q3 2025 revenue363Villers-lès-Nancy, 5 November 2025 - 6:00 PM (CET) PRESS RELEASE Revenue at 30 September 2025: €172.2m+8.9% on a reported basis and +7.3% like-for-like Group revenue at 09/30/2025 (€m)2024Reported...
► Artikel lesen
26.09.25Equasens: 2025 half-year results299Villers-lès-Nancy, 26 September 2025 - 6:00 PM (CET) PRESS RELEASE 2025 half-year results Revenue: €116.0m (+7.4% reported and +6.4% like-for-like)Recurring EBITDA: €29.8m (+5.5%)Current Operating...
► Artikel lesen
EQUASENS Aktie jetzt für 0€ handeln
31.07.25Equasens: H1 revenue at 30 June 2025: €116.0m548Villers-lès-Nancy (France), 31 July 2025 - 6:00 PM (CET) PRESS RELEASE H1 revenue at 30 June 2025: €116.0m+7.4% on a reported basis and +6.4% like-for-like H1 2025 Group revenue (€m)2024Reported...
► Artikel lesen
03.07.25Equasens: Appointment at the head of the Pharmagest Division338Villers-lès-Nancy (France), July 03, 2025 - 06:00pm (CET) Press Release Equasens announces the departure of Damien VALICON, as Deputy Chief Executive Officer and Director of the Pharmagest Division...
► Artikel lesen
02.07.25Dividendenbekanntmachungen (02.07.2025)8.791 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  AECOM  US00766T1007  0,26 USD  0,2202 EUR  AMADEUS IT GROUP SA  ES0109067019 - 0,89 EUR  ASSECO SOUTH EASTERN EUROPE SA  PLASSEE00014  1...
► Artikel lesen
01.07.25Equasens: General meeting - Results of the votes268Villers-lès-Nancy, 1st July 2025 - 07:00 p.m. (CET) PRESS RELEASE RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 25 JUNE 2025 Number of shares comprising...
► Artikel lesen
30.06.25Equasens: acquisition of DIS and RESURGENCES BUSINESSES472Villers-lès-Nancy (France), 30 June 2025 - 06:00 PM (CET) PRESS RELEASE EQUASENS ACQUIRES DIS AND RESURGENCES BUSINESSES, STRENGTHENING ITS POSITION IN THE MARKET OF SOFTWARE SOLUTIONS FOR HEALTHCARE...
► Artikel lesen
12.05.25Equasens: Q1 revenue at 31 March 2025549Villers-lès-Nancy, 12 May 2025 - 6:00 PM (CET) PRESS RELEASE Q1 revenue at 31 March 2025: €57.0m+ 6.9% growth on a reported basis and + 5.9% like-for-like Q1 2025 REVENUE (€m)2024Reported basis2025Reported...
► Artikel lesen
28.03.25Equasens: 2024 annual results664Villers-lès-Nancy, 28 March 2025 - 6:00 p.m. (CET) PRESS RELEASE 2024 annual results Full-year results adversely affected by difficult economic conditions in H1 combined with continuing investment...
► Artikel lesen
10 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1